SCHEMBL30706332

SCHEMBL30706332

Cc1ccc(F)cc1NC(=O)N1Cc2cn[nH]c2C1(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.41
MAPK1 P28482 3/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 2/20 0.38
GAA P10253 1/20 0.38
CCNA2 P20248 6/20 0.38
CDK2 P24941 6/20 0.38
CCNA1 P78396 6/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
PKM P14618 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
HTT P42858 1/20 0.37
TSHR P16473 1/20 0.36
PLAT P00750 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30706325 0.90 CYP1A2 (0.46) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL30706326 0.90 CYP1A2 (0.46) MAPTALDH1A1GAAMEN1KMT2A
SCHEMBL30706334 0.85 SMN1; SMN2 (0.44) MAPTNPSR1ALDH1A1HPGDMEN1
SCHEMBL30706333 0.85 SMN1; SMN2 (0.44) MAPTNPSR1ALDH1A1HPGDMEN1
SCHEMBL30706322 0.83 NR1H2 (0.35) CCNA2CDK2CCNA1
SCHEMBL30706330 0.82 NPC1 (0.44) KDM4EMAPTNPSR1GAAKMT2A
SCHEMBL30706324 0.77 NR1H2 (0.34) CCNA2CDK2CCNA1
SCHEMBL30706343 0.77 MAPK1 (0.39) KDM4EMAPK1MAPTNPSR1ALDH1A1
SCHEMBL30706327 0.75 LCK (0.38) MAPK1MAPTNPSR1GAARAB9A
SCHEMBL30706328 0.75 LCK (0.38) MAPK1MAPTNPSR1GAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12304913-B2 Dihydropyrrolopyrazole derivative UBE INDUSTRIES, LTD. (JP) 2025-05-20 US claimed
EP-3885347-B1 DIHYDROPYRROLOPYRAZOLE DERIVATIVE UBE CORP (JP) 2023-11-22 EP claimed
US-12304913-B2 Dihydropyrrolopyrazole derivative UBE INDUSTRIES, LTD. (JP) 2025-05-20 US disclosed
EP-3885347-B1 DIHYDROPYRROLOPYRAZOLE DERIVATIVE UBE CORP (JP) 2023-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12304913-B2 Dihydropyrrolopyrazole derivative CBR3, SLC13A3, CYP3A5 KDM4E 4518/4885MAPK1 851/4885MAPT 3585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.